Envisaged indication: Treatment of cancer
Showing 1 - 25 of >10,000
Ultra-rapid BRCA1/2 Status Screening Test in Theranostic
Not yet recruiting
- Breast Cancer
- Questionnaires
- Communication of the results of the BRCA1/2 ultra rapid test
- (no location specified)
Oct 26, 2023
Esophagus Adenocarcinoma Trial in Frankfurt (Durvalumab, FLOT, mFOLFOX-6)
Not yet recruiting
- Esophagus Adenocarcinoma
- Durvalumab
- +3 more
-
Frankfurt, GermanyInstitute of Clinical Cancer Research, University Cancer Center
Jan 26, 2023
Endometrial Tumors, Endometrial Tumor Malignant, Endometrial Tumor Malignant Stage I Trial in Beijing (Indication-extended
Recruiting
- Endometrial Neoplasms
- +4 more
- Indication-extended Fertility-sparing Therapy
-
Beijing, Beijing, ChinaPeking University People's Hosoital
Jul 12, 2023
Genetic Predisposition, Breast Cancer Trial in Montpellier (Prophylactic mastectomy with immediate breast reconstruction)
Recruiting
- Genetic Predisposition
- Breast Cancer
- Prophylactic mastectomy with immediate breast reconstruction
-
Montpellier, Hérault, FranceMontpellier University Hospital
Dec 9, 2022
Esophageal Tumor, Rectal Tumors Trial in Paris (fiducial markers placement)
Completed
- Esophageal Neoplasm
- Rectal Neoplasms
- fiducial markers placement
-
Paris, FranceUlriikka CHAPUT
Dec 2, 2022
Breast Cancer Female Trial in France (HYPOFRACTIONATED, NORMOFRACTIONATED)
Active, not recruiting
- Breast Cancer Female
- HYPOFRACTIONATED
- NORMOFRACTIONATED
-
Amiens, France
- +27 more
Oct 24, 2022
Sentinel Node Extended in Squamous Cell Vulvar Cancer
Recruiting
- Vulva Cancer
- Sentinel Lymph Node
- Sentinel node biopsy
-
Stockholm, Stockholms Lan, Sweden
- +3 more
Aug 17, 2022
Breast Cancer Trial in Shanghai (Hypofractionated radiotherapy, Conventional radiotherapy)
Recruiting
- Breast Cancer
- Hypofractionated radiotherapy
- Conventional radiotherapy
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiaotong University School of Medicine
May 29, 2022
Fibrosis, Breast Cancer Trial in France, Luxembourg (Thermal cure with a primary dermatological indication)
Not yet recruiting
- Fibrosis
- Breast Cancer
- Thermal cure with a primary dermatological indication
-
Bordeaux, France
- +7 more
May 15, 2023
Psychological Trial in Rome (psychological-clinical intervention with three days of expressive writing by Pennebaker)
Recruiting
- Psychological
- psychological-clinical intervention with three days of expressive writing by Pennebaker
-
Rome, ItalySant'Andrea Hospital, Faculty of Medicine and Psychology "La Sap
Nov 8, 2022
Use of Ketamine in Treatment of Refractory Chronic Pain in
Recruiting
- Cancer
- +3 more
- Ketamine use in CLCC sites (indication and administration protocol)
-
Bordeaux, France
- +11 more
Mar 14, 2022
Stomach Cancer, Undifferentiated Type, Expanded Indication of Endoscopic Resection Trial in Goyang (Endoscopic submucosal
Recruiting
- Stomach Cancer
- +2 more
- Endoscopic submucosal dissection
- Surgery
-
Goyang, Gyeonggi, Korea, Republic ofNational Cancer Center, Korea
Sep 2, 2021
Melanoma, NSCLC, Hepatocellular Carcinoma Trial in Pittsburgh (Nivolumab or Pembrolizumab (dependent upon approved indication),
Recruiting
- Melanoma
- +7 more
- Nivolumab or Pembrolizumab (dependent upon approved indication)
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Feb 10, 2022
Prostate Adenocarcinoma, Radiation Toxicity Trial in Limassol (External beam radiation therapy, High-dose-rate brachytherapy,
Recruiting
- Prostate Adenocarcinoma
- Radiation Toxicity
- External beam radiation therapy, High-dose-rate brachytherapy
- Goserelin 10.8 mg
-
Limassol, CyprusGerman Oncology Center
Aug 6, 2021
Breast Cancer Surgery Trial in Tübingen (Sonographically assisted breast surgery, Conventional breast surgery)
Recruiting
- Breast Cancer Surgery
- Sonographically assisted breast surgery
- Conventional breast surgery
-
Tübingen, BW, GermanyDepartment for Women's Health
Jun 22, 2021
Radiation Enteritis Trial in Chengdu (Tetrahydrobiopterin)
Recruiting
- Radiation Enteritis
-
Chengdu, Sichuan, Chinaest China Second Hospital of Sichuan University
Feb 25, 2022
Healthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive
Completed
- Healthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive Prostate Cancer)
-
Berlin, GermanyResearch Site
Apr 8, 2021
Solid Tumors Trial in Worldwide (Regorafenib, (Stivarga, BAY73-4506), Nivolumab (Opdivo))
Active, not recruiting
- Solid Tumors
- Regorafenib, (Stivarga, BAY73-4506)
- Nivolumab (Opdivo)
-
Duarte, California
- +33 more
Aug 18, 2022
Sepsis, Acute Kidney Injury, Septic Shock Trial in Worldwide (Subject management guided by NephroCheck® test, Standard of Care)
Terminated
- Sepsis
- +2 more
- Subject management guided by NephroCheck® test
- Standard of Care
-
Shreveport, Louisiana
- +11 more
Feb 28, 2022
Ovarian Tumors, Sarcopenia Trial in Chambéry (Sarcopenia diagnostic test)
Recruiting
- Ovarian Neoplasms
- Sarcopenia
- Sarcopenia diagnostic test
-
Chambéry, Savoie, FranceCentre Hospitalier Metropole Savoie
Apr 17, 2023
Rate of Return to Sport After Total Knee Prosthesis: Comparison
Not yet recruiting
- Knee Arthropathy
- total knee prosthesis
-
Biarritz, FranceClinique Aguiléra
Jun 23, 2023
Advanced Solid Tumor, NSCLC, Hepatocellular Carcinoma Trial in Canton (CHS-006 (anti-TIGIT), toripalimab (anti-PD-1))
Not yet recruiting
- Advanced Solid Tumor
- +2 more
- CHS-006 (anti-TIGIT)
- toripalimab (anti-PD-1)
-
Canton, OhioGabrail Cancer and Research Center
Feb 23, 2023
Blood Transfusion in Patients With Lung Cancer
Recruiting
- Transfusion-Transmitted Infection
- Blood transfusion
-
Trabzon, TurkeyDepartment of Chest Diseases, Division Of Intensive Care Medicin
Oct 18, 2022